Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Botox Alternative May Safely Smooth Forehead Lines

Reloxin is already approved outside US, but not all experts are convinced by new study

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Amenorrhea
Amniocentesis
Amniocentesis and CVS
Anovulation
More...

Related Healthscout Videos
 border=
Incision-Free Bladder Surgery
Tracking Breast Cancer with Less Pain
5 Breast Cancer Myths
Software Makes Childbirth Safer
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Bans on Same-Sex Marriage May Affect Mental Health
Certain Bone Drugs May Lower Breast Cancer Risk
Treating Gum Disease May Thwart Preterm Births
Freezing Technique May Stop Breast Cancer
More...

MONDAY, March 16 (HealthDay News) -- A new type of Botox drug called Reloxin appears safe and effective in reducing forehead wrinkles, a new study finds.

The use of Botox to reduce forehead wrinkles and frown lines has long been a mainstay of cosmetic medicine. The medication works by preventing face muscles from contracting, an effect that lasts for several months.

Text Continues Below



As an alternative to Botox, Reloxin is now approved in 23 countries outside the United States to smooth wrinkles, the researchers noted. The drug has also been used outside the United States for more than 15 years to treat neurological disorders.

One of the differences between Botox and Reloxin is that Reloxin has less protein in its formula, noted Dr. Kamran Jafri, from Jafri Craniofacial Plastic Surgery, New York City. Reloxin also contains fewer antigens, which cause the drug to break down more quickly, said Jafri, who was not involved in the new study.

"Theoretically, because Reloxin has less of a protein load the body will break it down at a slower rate. That means from a clinical perspective that it should last longer than Botox," he said. "However, some of the early trials are showing that Botox actually lasts longer than Reloxin."

Another difference between the drugs is that Reloxin defuses more in the tissue than Botox, Jafri said. "Botox typically defuses in about a one centimeter radius, Reloxin can go anywhere from one to three centimeters," he said. "That's a good thing for the forehead, where you can give fewer injections, but it's a bad thing for, say, crow's feet, where unless you are an experienced injector and you know the muscles very well, it could spread to other muscles and cause a droopy eyebrow or droopy eyelid," he explained.

In this phase III trial, Reloxin's wrinkle-smoothing effects lasted more than 13 months. And although the drug is still awaiting approval from the U.S. Food and Drug Administration, it could someday become a serious competitor to Botox, the researchers said.

Page:  1 | 2 | 3 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 3/16/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Ronald Moy, M.D., Moy-Fincher Medical Group, Los Angeles; Brent Moelleken, M.D., plastic and reconstructive surgeon, Beverly Hills and Santa Barbara, Calif.; Jeffrey C. Salomon, M.D., assistant clinical professor, plastic surgery, Yale University School of Medicine, New Haven, Conn.; Kamran Jafri, M.D., Jafri Craniofacial Plastic Surgery, New York City; March/April 2009 Archives of Facial Plastic Surgery


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy